Skip to main content
TipRanks
Go Ultimate75% OFF

Terry Allan Bateman Insider Profile

4 Followers

Terry Allan Bateman, Director at Eterna Therapeutics, holds 503.96K shares in Eterna Therapeutics (Ticker: ERNA). Most recently, Terry Allan Bateman Bought 328,125 shares of Eterna Therapeutics on Mar 22, 2010 for an estimated value of $55.78K.

Terry Allan Bateman's Trading History

ERNA
Eterna Therapeutics
Mar 22, 2010DirectorInformative Buy55.78K$851.69K
ERNA
Insider Shares: 503.96K (0.55%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 22, 2010Informative Buy$55.78K328,125$0.17-8.60%
Jun 29, 2009Informative Buy$28.39K175,833$0.16+2.00%

You May Also Like

Terry Allan Bateman insider profile FAQ

What is the percentage of profitable transactions made by Terry Allan Bateman?
The percentage of profitable transactions made by Terry Allan Bateman is 50%.
What is the average return per transaction made by Terry Allan Bateman?
The average return per transaction made by Terry Allan Bateman is -3.30%.
What stocks does Terry Allan Bateman hold?
Terry Allan Bateman holds: ERNA stocks.
What was Terry Allan Bateman’s latest transaction?
Terry Allan Bateman’s latest transaction was an Informative Buy of $55.78K.
What was Terry Allan Bateman's most profitable transaction?
Terry Allan Bateman’s most profitable transaction was an Informative Buy of ERNA stock on June 29, 2009. The return on the trade was 2.00%.
What is Terry Allan Bateman's role in Eterna Therapeutics?
Terry Allan Bateman's role in Eterna Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.